The U.S. Food and Drug Administration approved Flonase Allergy Relief for the over-the-counter treatment of nasal allergy symptoms in July 2014. The product is expected to launch in Spring 2015, just in time for the allergy season.

The U.S. Food and Drug Administration approved Nasacort Allergy 24HR for the over-the-counter treatment of nasal allergy symptoms. The nasal spray will be available for purchase over-the-counter in its original, full prescription strength starting in the spring of 2014; the product will be available on shelves as early as February 2014.

The U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta on December 11, 2013. The prescription medication, duloxetine delayed-release capsules, is used to treat depression other psychological conditions. Signs and symptoms of depression include depressed mood, loss of interest in once-pleasurable activities, significant appetite or weight change, insomnia or hypersomnia, restlessness/pacing, increased fatigue, impaired concentration, feelings of worthlessness or guilt, and thoughts of suicide or suicide attempts.

The U.S. Food and Drug Administration announced on November 7, 2013 that partially hydrogenated oils (the primary dietary source for artificial trans fats) in processed foods are not “generally recognized as safe” for use in food. The FDA established a 60-day comment period to collect additional data and to help them get input on the approximate amount of time needed for manufacturers to reformulate their products and eliminate trans fats from their food products.